HT-29 cell surface (HT-29)

HT-29 is a human colorectal adenocarcinoma cell line that is extensively used in biomedical research as a model for the study of colon cancer and intestinal cell biology (ATCC, 2023). The HT-29 cell surface is not a single molecular target but a complex interface containing various receptors, glycoproteins, and transporters, such as the Epidermal Growth Factor Receptor (EGFR) and Carcinoembryonic Antigen (CEA) (PubMed, PMID: 25632391). While drugs and antibodies are often tested for their ability to bind to the HT-29 cell surface, the surface itself represents a cellular compartment rather than a discrete therapeutic entity. It is commonly employed in assays to evaluate the efficacy of targeted therapies, drug delivery systems, and the mechanisms of epithelial transport (NCBI, PMC3541109). Consequently, identifying the HT-29 cell surface as a target is considered incorrect in a pharmacological context, as therapeutic targets must be specific molecules like proteins or nucleic acids. Researchers utilize this cell line to understand how cancer cells interact with their environment and respond to potential treatments.

Other names

HT-29 cell lineHT29HT-29 colorectal adenocarcinoma cell surface

Not applicable as this refers to a cell line surface rather than a specific molecular target.